Synthetic Blood Substitute Market
完整報告名稱與涵蓋範圍
Synthetic Blood Substitute Market, Share & Trends Analysis Report, By Application (Cardiovascular Diseases, Malignant Neoplasma, Injuries, Neonatal Conditions, Organ Transplant, Maternal Condition), By End-use, By Product, By Source, By Component, By Configuration, By Region, and Segment Forecasts, 2024-2031
報告摘要
Valued at USD 7.26 Bn as of 2023, the global Synthetic Blood Substitute Market is set to climb to USD 20.75 Bn by 2031, reflecting a compound annual growth rate of 14.3% over the 2024–2031 period.
Synthetic Blood Substitute encompasses The global synthetic blood substitute industry is rapidly evolving, focusing on the development of artificial blood products to overcome the limitations of traditional blood transfusions. The sector has gained traction as organizations seek innovative approaches to address evolving healthcare challenges.
The market's upward path is driven by mounting healthcare spending, technological evolution, and the mounting focus on personalized and precision-based approaches in healthcare.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold meaningful shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Synthetic Blood Substitute Market Snapshot
Chapter 4. Global Synthetic Blood Substitute Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Synthetic Blood Substitute Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Synthetic Blood Substitute Industry Trends
Chapter 5. Synthetic Blood Substitute Market Segmentation 1: By Product, Estimates & Trend Analysis
5.1. Market Share by Product, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Product:
5.2.1. Hemoglobin-Based Oxygen Carriers (HBOCs)
5.2.2. Perfluorocarbon Emulsions (PFCs)
5.2.3. Stem Cell-Derived Red Blood Cells
5.2.4. Others
Chapter 6. Synthetic Blood Substitute Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following
6.2.1. Cardiovascular Diseases
6.2.2. Malignant Neoplasma
6.2.3. Injuries
6.2.4. Neonatal Conditions
6.2.5. Organ Transplant
6.2.6. Maternal Condition
6.2.7. Others
Chapter 7. Synthetic Blood Substitute Market Segmentation 3: By Source, Estimates & Trend Analysis
7.1. Market Share by Source, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Sources:
7.2.1. Human Blood
7.2.2. Microorganism Based Recombinant HB
7.2.3. Synthetic Polymers
7.2.4. Stem Cells
7.2.5. Others
Chapter 8. Synthetic Blood Substitute Market Segmentation 4: By Component, Estimates & Trend Analysis
8.1. Market Share by Component, 2023 & 2031
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Components:
8.2.1. Red Blood Cell Substitutes
8.2.2. Platelet Substitutes
8.2.3. Plasma Substitutes
Chapter 9. Synthetic Blood Substitute Market Segmentation 5: By Configuration, Estimates & Trend Analysis
9.1. Market Share by Configuration, 2023 & 2031
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Configuration:
9.2.1. Injectable Solutions
9.2.2. Powdered Forms
9.2.3. Infusion Bags
9.2.4. Capsules and Tablets
9.2.5. Others
Chapter 10. Synthetic Blood Substitute Market Segmentation 6: By End-use, Estimates & Trend Analysis
10.1. Market Share by End-use, 2023 & 2031
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following End-use:
10.2.1. Hospitals
10.2.2. Ambulatory Surgical Centers
10.2.3. Military and Defense
10.2.4. Research Laboratories
10.2.5. Emergency Services
10.2.6. Others
Chapter 11. Synthetic Blood Substitute Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. Global Synthetic Blood Substitute Market, Regional Snapshot 2023 & 2031
11.2. North America
11.2.1. North America Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
11.2.1.1. US
11.2.1.2. Canada
11.2.2. North America Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
11.2.3. North America Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.2.4. North America Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Source, 2024-2031
11.2.5. North America Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Component, 2024-2031
11.2.6. North America Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Configuration, 2024-2031
11.2.7. North America Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2024-2031
11.3. Europe
11.3.1. Europe Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
11.3.1.1. Germany
11.3.1.2. U.K.
11.3.1.3. France
11.3.1.4. Italy
11.3.1.5. Spain
11.3.1.6. Rest of Europe
11.3.2. Europe Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024- 2031
11.3.3. Europe Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.3.4. Europe Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Source, 2024-2031
11.3.5. Europe Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Component, 2024-2031
11.3.6. Europe Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Configuration, 2024-2031
11.3.7. Europe Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2024-2031
11.4. Asia Pacific
11.4.1. Asia Pacific Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
11.4.1.1. India
11.4.1.2. China
11.4.1.3. Japan
11.4.1.4. Australia
11.4.1.5. South Korea
11.4.1.6. Hong Kong
11.4.1.7. Southeast Asia
11.4.1.8. Rest of Asia Pacific
11.4.2. Asia Pacific Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
11.4.3. Asia Pacific Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.4.4. Asia Pacific Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts By Source, 2024-2031
11.4.5. Asia Pacific Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Component, 2024-2031
11.4.6. Asia Pacific Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts By Configuration, 2024-2031
11.4.7. Asia Pacific Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2024-2031
11.5. Latin America
11.5.1. Latin America Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
11.5.1.1. Brazil
11.5.1.2. Mexico
11.5.1.3. Rest of Latin America
11.5.2. Latin America Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
11.5.3. Latin America Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
11.5.4. Latin America Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Source, 2024-2031
11.5.5. Latin America Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Component, 2024-2031
11.5.6. Latin America Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Configuration, 2024-2031
11.5.7. Latin America Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2024-2031
11.6. Middle East & Africa
11.6.1. Middle East & Africa Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
11.6.1.1. GCC Countries
11.6.1.2. Israel
11.6.1.3. South Africa
11.6.1.4. Rest of Middle East and Africa
11.6.2. Middle East & Africa Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Product, 2024-2031
11.6.3. Middle East & Africa Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by application, 2024-2031
11.6.4. Middle East & Africa Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Source, 20242031
11.6.5. Middle East & Africa Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Component, 2024-2031
11.6.6. Middle East & Africa Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by Configuration, 2024-2031
11.6.7. Middle East & Africa Synthetic Blood Substitute Market Revenue (US$ Million) Estimates and Forecasts by End-use, 2024-2031
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. Aurum Biosciences
12.2.1.1. Business Overview
12.2.1.2. Key Product/Service Products
12.2.1.3. Financial Performance
12.2.1.4. Geographical Presence
12.2.1.5. Recent Developments with Business Strategy
12.2.2. HEMARINA
12.2.3. Hemoglobin Oxygen Therapeutics LLC
12.2.4. KaloCyte, Inc.
12.2.5. Spheritech Ltd
12.2.6. VisusMed Medical Center
12.2.7. OPKO Health, Inc.
12.2.8. NuvOx Pharma
12.2.9. Prolong Pharmaceuticals
12.2.10. Boston Pharmaceuticals
12.2.11. ATPL
12.2.12. Baxter
12.2.13. Biopharma corp
12.2.14. Dentritech, Inc
12.2.15. NORTHFIELD LABORATORIES INC.
12.2.16. Alliance Pharma PLC
12.2.17. Oxygen Biotherapeutics
12.2.18. Sanguine Corp
12.2.19. VirTech Bio
12.2.20. Oxyvita, Inc.
12.2.21. Other Key Companies
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們